Search

Author/Creator Gopal, Ajay K

1. Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study. Issue 8 (August 2021)

Authors:
Lynch, Ryan C; Cassaday, Ryan D; Smith, Stephen D; Fromm, Jonathan R; Cowan, Andrew J; Warren, Edus H; Shadman, Mazyar S; Shustov, Andrei; Till, Brian G; Ujjani, Chaitra S; Libby, Edward N; Philip, Mary; Coye, Hilary; Martino, Christen N; Bhark, Sandra L; Morris, Karolyn; Rasmussen, Heather; Behn...
Journal:
Lancet
Issue:
Volume 8:Issue 8(2021)
Page Start:
e562
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study. Issue 3 (March 2018)

Authors:
Barr, Paul M; Li, Hongli; Burack, W Richard; LeBlanc, Michael; Smith, Sonali M; Gopal, Ajay K; Floyd, Justin D; Persky, Daniel O; Press, Oliver W; Fisher, Richard I; Friedberg, Jonathan W
Journal:
Lancet
Issue:
Volume 5:Issue 3(2018)
Page Start:
e102
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial setting. (October 2016)

Authors:
Gopal, Ajay K; Pro, Barbara; Connors, Joseph M; Younes, Anas; Engert, Andreas; Shustov, Andrei R; Chi, Xuedong; Larsen, Emily K; Kennedy, Dana A; Sievers, Eric L
Journal:
Clinical trials
Issue:
Volume 13:Number 5(2016)
Page Start:
545
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗